Page last updated: 2024-08-17

cycloheximide and Myxoid Liposarcoma

cycloheximide has been researched along with Myxoid Liposarcoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albalat, R; Ron, D; Zinszner, H1

Other Studies

1 other study(ies) available for cycloheximide and Myxoid Liposarcoma

ArticleYear
A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP.
    Genes & development, 1994, Nov-01, Volume: 8, Issue:21

    Topics: 3T3 Cells; Animals; Base Sequence; CCAAT-Enhancer-Binding Proteins; Cell Division; Cell Transformation, Neoplastic; Chromosome Aberrations; Cycloheximide; DNA Damage; DNA-Binding Proteins; Genetic Vectors; HeLa Cells; Heterogeneous Nuclear Ribonucleoprotein A1; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Heterogeneous-Nuclear Ribonucleoprotein Group C; Heterogeneous-Nuclear Ribonucleoproteins; Humans; Liposarcoma, Myxoid; Mice; Mice, Nude; Molecular Sequence Data; Mutagenesis, Insertional; Neoplasm Proteins; Nuclear Proteins; Oligodeoxyribonucleotides; Oncogenes; Recombinant Fusion Proteins; Ribonucleoproteins; RNA-Binding Protein EWS; RNA-Binding Protein FUS; RNA-Binding Proteins; Transcription Factor CHOP; Transcription Factors; Transplantation, Heterologous; Tumor Cells, Cultured

1994